HF
SANA icon

HRT Financial’s Sana Biotechnology SANA Stock Holding History

HRT Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,122
Closed -$147K – 2979
2023
Q3 		$147K Buy
+38,122
New +$205K ﹤0.01% 1902
2022
Q4 		– Sell
-67,970
Closed -$407K – 3040
2022
Q3 		$407K Buy
+67,970
New +$491K ﹤0.01% 1796

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

HRT Financial's SANA Position: Q4 2023 in Review

HRT Financial sold out of Sana Biotechnology (SANA) in Q4 2023, closing a stake of 38,122 shares — an estimated $147K sold.

HRT Financial first reported a position in SANA in Q3 2022 and held it in 2 quarters. The position peaked at $407K in Q3 2022. 132 funds tracked by Wall St. Rank hold SANA as of Q4 2023.

  • HRT Financial reported no remaining Sana Biotechnology position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 38,122 Sana Biotechnology shares in Q4 2023, an estimated $147K.
  • HRT Financial first reported a position in Sana Biotechnology in Q3 2022 and held it in 2 quarters.
  • HRT Financial's Sana Biotechnology position peaked at $407K in Q3 2022.
  • 132 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.